Advanced Search
Current and Breaking News for Professionals, Consumers and Media



Click here to learn how to advertise on this site and for ad rates.

FDA Approval Author: FDA Consumer Health Information Last Updated: Nov 29, 2012 - 7:11:02 AM


FDA Statement on Fungal Meningitis Outbreak

By FDA Consumer Health Information
Oct 18, 2012 - 2:39:41 PM



Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust


Email this article
 Printer friendly page
(HealthNewsDigest.com) - CDC and FDA have confirmed the presence of a fungus known as Exserohilum rostratum in unopened medication vials of preservative-free methylprednisolone acetate (80mg/ml) from one of the three implicated lots from NECC (Lot #08102012@51, BUD 2/6/2013). The laboratory confirmation further links steroid injections from these lots from NECC to the multistate outbreak of fungal meningitis and joint infections. Testing on the other two implicated lots of methylprednisolone acetate and other NECC injectables continues.

CDC and state health departments estimate that approximately 14,000 patients may have received injections with medication from three implicated lots of methylprednisolone and nearly 97 percent of these patients have been contacted for further follow-up.

For more information:
http://www.fda.gov/Drugs/DrugSafety/ucm322734.htm

###

For advertising and promotion on HealthNewsDigest.com please contact Mike McCurdy: tvmike13@HealthNewsDigest.com or 877-634-9180
HealthNewsDigest.com is syndicated worldwide, to thousands of journalists in all media, and health-related websites. www.HealthNewsDigest.com

Top of Page

HealthNewsDigest.com

FDA Approval
Latest Headlines
+ FDA Approves New Drug for Advanced Prostate Cancer
+ U.S. Marshals Seize Food at New York-based Kosher Food Facility
+ Stimulant DMAA May Endanger Your Health, FDA Warns
+ FDA Issues Proposal to Improve the Quality of Automated Eternal Defibrillators
+ FDA Approves New Treatment for Late-stage Breast Cancer
+ FDA Approves Pomalyst for Advanced Multiple Myeloma
+ FDA Approval of Generic Version of Cancer Drug Doxil is Expected to Help Resolve Shortage
+ Beware of Fraudulent Flu Products
+ FDA Approves Three New Drug Treatments for Type 2 Diabetes
+ FDA Approves Gleevec for Children with Acute Lymphoblastic Leukemia

Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions